368 related articles for article (PubMed ID: 24360084)
1. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
Sobrinho G; Aguiar P
Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
[TBL] [Abstract][Full Text] [Related]
2. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
[TBL] [Abstract][Full Text] [Related]
4. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
5. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
6. [Superior vena cava thrombosis or stricture secondary to implanted central venous access: Six cases of endovascular and direct surgical treatment in cancer patients].
Fichelle JM; Baissas V; Salvi S; Fabiani JN
J Med Vasc; 2018 Feb; 43(1):20-28. PubMed ID: 29425537
[TBL] [Abstract][Full Text] [Related]
7. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?
Cho Y; Gwon DI; Ko GY; Ko HK; Kim JH; Shin JH; Yoon HK; Sung KB
Korean J Radiol; 2014; 15(1):87-94. PubMed ID: 24497797
[TBL] [Abstract][Full Text] [Related]
8. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
10. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
11. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
12. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
Lau KY; Tan LT; Wong WW; Lee AS
Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
[TBL] [Abstract][Full Text] [Related]
13. Superior vena cava stent placement: results with the Wallstent endoprosthesis.
Hennequin LM; Fade O; Fays JG; Bic JF; Jaafar S; Bertal A; Anthoine D; Bernadac PA
Radiology; 1995 Aug; 196(2):353-61. PubMed ID: 7617844
[TBL] [Abstract][Full Text] [Related]
14. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
[TBL] [Abstract][Full Text] [Related]
15. Stenting for superior vena cava obstruction in pediatric heart transplant recipients.
Sachdeva R; Seib PM; Burns SA; Fontenot EE; Frazier EA
Catheter Cardiovasc Interv; 2007 Nov; 70(6):888-92. PubMed ID: 17932887
[TBL] [Abstract][Full Text] [Related]
16. Endovascular treatment for superior vena cava occlusion or obstruction in a pediatric and young adult population: a 22-year experience.
Tzifa A; Marshall AC; McElhinney DB; Lock JE; Geggel RL
J Am Coll Cardiol; 2007 Mar; 49(9):1003-9. PubMed ID: 17336725
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Covered Versus Uncovered Stents for Benign Superior Vena Cava (SVC) Obstruction.
Haddad MM; Simmons B; McPhail IR; Kalra M; Neisen MJ; Johnson MP; Stockland AH; Andrews JC; Misra S; Bjarnason H
Cardiovasc Intervent Radiol; 2018 May; 41(5):712-717. PubMed ID: 29492630
[TBL] [Abstract][Full Text] [Related]
18. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
19. Stent insertion for malignant superior vena cava syndrome: effectiveness and long-term outcome.
Niu S; Xu YS; Cheng L; Cao C
Radiol Med; 2017 Aug; 122(8):633-638. PubMed ID: 28429206
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous stent placement in malignant cases of superior vena cava syndrome.
Baltayiannis N; Magoulas D; Anagnostopoulos D; Bolanos N; Sfyridis P; Georgiannakis E; Zografos P; Kayia A; Kayianni E; Sotirakoglou K; Chatzimichalis A
J BUON; 2005; 10(3):377-80. PubMed ID: 17357192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
